After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that ...

Among new hires, former Google Gemini engineering lead Amar Subramanya joined Microsoft AI as corporate vice-president.

The oncology drug created by Isomorphic Labs using Google DeepMind’s AlphaFold 3 tool could be pivotal for cancer treatment.

Microsoft's new model-agnostic MAI Diagnostic Orchestrator (MAI-DxO) achieved 85.5 percent diagnostic accuracy—outperforming ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Now Google’s DeepMind division says it’s made a leap in trying to understand the code with AlphaGenome, an AI model that predicts what effects small changes in DNA will have on an array of molecular ...

DeepMind, Google's artificial intelligence arm, has plans to break into healthcare via a new partnership with Imperial College London and the Royal Free London National Health Services Foundation ...

This AI system can analyze up to one million DNA letters at once, predicting how tiny changes in noncoding regions trigger ...

DeepMind, Google's artificial intelligence arm, is building a data auditing project for DeepMind Health, according to a DeepMind blog post. Skip to main ... such as predictive analytics research.

Carolina Parada, head of robotics at Google DeepMind, says this approach to AI robotics could make robots more reliable in ...

Google DeepMind researchers believe that by building for India's linguistic, economic, and cultural complexity, their work ...

The team behind the development of the Streams mobile app will be joining Google, DeepMind Health has confirmed, nearly a week after it was announced that Geisinger CEO Dr David Feinberg was taking on ...